SGP
SGP
US85220G1094
SpyGlass Pharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
833.52M EUR
744.51M EUR
866.24M EUR
--
Enterprise Value
590.94M EUR
523M EUR
628.94M EUR
--
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-9.27x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.59x
3.2x
3.46x
--
EV/Revenue
--
--
--
--
EV/EBITDA
-9.67x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
--
-6.68%
-4.54%
--
ende